市场调查报告书
商品编码
1451747
2024-2032 年按设备类型、应用程式、最终用户和地区分類的一次性医疗设备再处理市场报告Single-use Medical Device Reprocessing Market Report by Device Type, Application, End User, and Region 2024-2032 |
2023年,全球一次性医疗器材再处理市场规模达到8.052亿美元。展望未来, IMARC Group预计到2032年该市场将达到23.82亿美元,2024-2032年复合年增长率(CAGR)为12.6%。慢性疾病盛行率的上升、外科手术和品质控制方法的增加、以及对永续性和减少医疗废物的日益关注是推动市场的一些主要因素。
一次性医疗器械再处理是医疗保健行业的一种做法,旨在透过收集、清洁、消毒和翻新设计和标记为一次性使用的医疗器械来降低成本并减少环境废物。这些设备经过适当的处理后,将重新引入医疗环境以供后续患者使用。这种方法之所以受到关注,是因为它有可能降低与医疗设备采购相关的费用,同时也解决了有关一次性医疗用品对生态影响的担忧。该过程通常涉及严格的步骤,以确保再处理设备的安全性和有效性。根据设备是否适合再处理进行收集和分类。然后,它们会经过一系列细緻的程序,包括清洁、消毒、检查、测试和灭菌。
慢性疾病盛行率的上升以及外科手术数量的增加正在推动全球市场的发展。此外,对永续性和减少医疗废弃物的日益关注导致人们对再处理一次性设备的兴趣增加。再处理可减少最终进入垃圾掩埋场或焚化炉的医疗废弃物量,从而最大限度地减少医疗保健对环境的影响。此外,各国监管机构也为某些一次性医疗器材的安全再处理提供了指导方针和批准。这些法规透过确保再处理设备符合严格的安全和品质标准来支援再处理市场的成长。再处理技术和製程的不断进步提高了该过程的有效性和安全性。这些进步包括更好的清洁、灭菌和品质控制方法,使再加工的设备更适合临床使用。此外,一次性设备后处理标准和法规的製定也促进了市场的成长。明确的指南使医疗机构对再处理设备的安全性和有效性充满信心。
成本控制与预算压力
在医疗保健支出不断增加和财务紧张的环境下,医院和诊所正在寻求创新方法,以在不影响患者护理的情况下最大限度地利用资源。一次性医疗设备通常在一位患者使用后被丢弃,导致更换时产生大量经常性费用。对这些设备进行再处理可以大幅节省成本,因为翻新设备可以以新设备成本的一小部分重新引入临床环境。该策略不仅减少了采购费用,还透过减少频繁补给的需求来提高营运效率。透过将再处理节省的资金重新分配到患者护理和基础设施增强的其他关键领域,医疗机构可以减轻财务压力,同时保持高标准的医疗服务提供。
环境永续性和减少废物
医疗保健产业产生大量医疗废弃物,其中大部分来自一次性医疗设备。这些一次性用品会导致垃圾掩埋场中不可生物降解材料的积累,可能造成环境危害。再处理透过彻底清洁、消毒和灭菌来延长这些设备的使用寿命,从而解决了这个问题。透过重复使用再处理的设备,医疗机构可以显着减少医疗废物的产生量,从而促进对生态更加负责的医疗保健方法。这与更广泛的社会向环保实践的转变一致,并将医疗机构定位为患者健康和环境的负责任的管理者。随着监管机构和患者群体越来越重视永续性,采用一次性医疗器材再处理成为寻求减少生态足迹的医疗保健提供者的合理选择。
监管支援和技术进步
监管机构认识到在严格的品质控制下进行后处理的潜在好处,已製定指南和标准以确保患者安全。随着这些法规的发展以确保再处理设备的功效,医疗机构更倾向于将再处理纳入其实践,从而促进市场成长。此外,技术进步改变了后处理格局。清洁剂、消毒方法和灭菌技术的创新能够更有效地去除污染物,使再处理的设备与新设备一样安全可靠。这些进步也有助于增强品质保证,减少不良事件的可能性。监管支援和技术进步的结合提高了一次性医疗器材再处理的可信度,增强了医疗保健提供者之间的信任并鼓励更广泛的采用。
The global single-use medical device reprocessing market size reached US$ 805.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2382.0 Million by 2032, exhibiting a growth rate (CAGR) of 12.6% during 2024-2032. The rising prevalence of chronic disorders, along with the increasing number of surgical procedures, and quality control methods, and the growing focus on sustainability and reducing medical waste are some of the major factors propelling the market.
Single-use medical device reprocessing is a practice within the healthcare industry aimed at mitigating costs and reducing environmental waste by collecting, cleaning, disinfecting, and refurbishing medical devices that are designed and labeled for single-use. These devices, after appropriate processing, are then reintroduced into the medical setting for subsequent patient use. This approach has gained attention due to its potential to lower expenses associated with medical equipment procurement while also addressing concerns regarding the ecological impact of disposable medical items. The process typically involves rigorous steps to ensure the safety and efficacy of reprocessed devices. Devices are collected and sorted based on their suitability for reprocessing. They then undergo a series of meticulous procedures, including cleaning, disinfection, inspection, testing, and sterilization.
The rising prevalence of chronic disorders, along with the increasing number of surgical procedures, is driving the global market. Moreover, the growing focus on sustainability and reducing medical waste has led to increased interest in reprocessing single-use devices. Reprocessing helps minimize the environmental impact of healthcare by reducing the volume of medical waste that ends up in landfills or incinerators. Furthermore, regulatory agencies in various countries have provided guidelines and approvals for the safe reprocessing of certain single-use medical devices. These regulations support the growth of the reprocessing market by ensuring that reprocessed devices meet stringent safety and quality standards. Ongoing advancements in reprocessing technologies and techniques have improved the effectiveness and safety of the process. These advancements include better cleaning, sterilization, and quality control methods, making reprocessed devices more reliable for clinical use. Also, the establishment of standards and regulations for reprocessing single-use devices has contributed to the growth of the market. Clear guidelines provide healthcare facilities with confidence in the safety and effectiveness of reprocessed devices.
Cost Containment and Budget Pressures
In an environment of rising healthcare expenditures and financial constraints, hospitals and clinics are seeking innovative ways to maximize resource utilization without compromising patient care. Single-use medical devices are often discarded after a single patient use, leading to significant recurring expenses for replacements. Reprocessing these devices provides an avenue for substantial cost savings, as the refurbished devices can be reintroduced into the clinical setting at a fraction of the cost of new ones. This strategy not only reduces procurement expenses but also contributes to operational efficiency by curtailing the need for frequent supply replenishment. By reallocating funds saved through reprocessing to other critical areas of patient care and infrastructure enhancement, healthcare institutions can alleviate financial pressures while maintaining high standards of medical service delivery.
Environmental Sustainability and Waste Reduction
The healthcare sector generates a significant amount of medical waste, much of which comes from single-use medical devices. These disposables contribute to the accumulation of non-biodegradable materials in landfills, potentially causing environmental harm. Reprocessing offers a solution to this concern by extending the lifespan of these devices through thorough cleaning, disinfection, and sterilization. By reusing reprocessed devices, healthcare facilities can significantly decrease the volume of medical waste generated, promoting a more ecologically responsible approach to medical care. This aligns with the broader societal shift towards environmentally conscious practices and positions healthcare institutions as responsible stewards of both patient health and the environment. As regulatory bodies and patient populations increasingly prioritize sustainability, the adoption of single-use medical device reprocessing becomes a logical choice for healthcare providers looking to reduce their ecological footprint.
Regulatory Support and Technological Advancements
Regulatory agencies, recognizing the potential benefits of reprocessing when conducted with stringent quality controls, have established guidelines and standards to ensure patient safety. As these regulations evolve to ensure the efficacy of reprocessed devices, healthcare facilities are more inclined to incorporate reprocessing into their practices, augmenting the market growth. Moreover, technological advancements have transformed the reprocessing landscape. Innovations in cleaning agents, disinfection methods, and sterilization technologies have enabled more effective removal of contaminants, rendering reprocessed devices comparably safe and reliable as new ones. These advancements also contribute to enhanced quality assurance, reducing the likelihood of adverse events. The marriage of regulatory support and technological progress enhances the credibility of single-use medical device reprocessing, fostering trust among healthcare providers and encouraging broader adoption.
IMARC Group provides an analysis of the key trends in each segment of the global single-use medical device reprocessing market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on device type, application and end user.
Class I Devices
Laparoscopic Graspers
Scalpels
Tourniquet Cuffs
Other Class I Devices
Class II Devices
Pulse Oximeter Sensors
Sequential Compression Sleeves
Catheters and Guidewires
Other Class II Devices
Class II devices dominate the market
The report has provided a detailed breakup and analysis of the market based on the device type. This includes class I devices (laparoscopic graspers, scalpels, tourniquet cuffs, and other class I devices), and class II devices (pulse oximeter sensors, sequential compression sleeves, catheters and guidewires, and other class II devices). According to the report, class II devices represented the largest segment.
Class II devices encompass a diverse range of medical instruments that pose a moderate to high risk to patients. These devices often require a more complex reprocessing process due to their intricate designs, various components, and critical functionalities. Class II devices are widely utilized across multiple medical specialties, including cardiology, orthopedics, and gastroenterology. This broad usage translates into a higher volume of devices that can be targeted for reprocessing. Furthermore, the cost implications of Class II devices play a pivotal role. Several devices are expensive to procure, and their disposability contributes significantly to healthcare expenditures. As healthcare providers face mounting pressure to optimize budget allocation, the potential for cost savings through reprocessing becomes particularly attractive. The reprocessing of Class II devices offers a practical solution to mitigate financial burdens while still adhering to stringent quality and safety standards.
General Surgery
Anesthesia
Arthroscopy and Orthopaedic Surgery
Cardiology
Gastroenterology
Gynaecology
Urology
Others
The report has provided a detailed breakup and analysis of the market based on the application. This includes general surgery, anesthesia, arthroscopy and orthopaedic surgery, cardiology, gastroenterology, gynaecology, urology, and others.
General surgery encompasses a wide array of procedures that address a range of conditions, from routine to complex. This diversity in surgical interventions contributes to the substantial size of the general surgery application segment within the reprocessing market. Single-use devices utilized in general surgery procedures, such as endoscopic tools, laparoscopic instruments, and trocars, are often costly, driving up healthcare expenditures. As hospitals and surgical centers face mounting financial pressures, reprocessing these devices becomes an attractive strategy to control costs without compromising patient safety.
On the other hand, cardiology procedures, ranging from diagnostic angiography to complex interventions, such as angioplasty and stent placement, heavily rely on a variety of single-use medical devices. These devices, often intricate and specialized, contribute to the substantial size of the cardiology application segment. The utilization of reprocessed devices in cardiology not only addresses the financial burden of procuring expensive single-use instruments but also aligns with the industry's shift towards sustainability.
Hospitals
Ambulatory Surgical Centers
Others
Hospitals dominate the market
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.
Hospitals are at the forefront of sustainability efforts within the healthcare sector. With increased global awareness of environmental concerns, hospitals are under pressure to reduce their ecological footprint. Reprocessing single-use devices aligns perfectly with this sustainability objective by reducing the volume of medical waste generated. By reprocessing devices instead of disposing of them after a single use, hospitals contribute to waste reduction and minimize their impact on the environment. The adoption of reprocessed devices by hospitals also benefits from advancements in reprocessing technologies and the growing support from regulatory agencies. These factors collectively impel the credibility and safety of reprocessed devices, assuaging concerns about their efficacy. As hospitals focus to provide the best possible care to their patients, the assurance of regulatory compliance and technological sophistication plays a pivotal role in their decision to adopt reprocessed devices.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest single-use medical device reprocessing market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America boasts an advanced and well-established healthcare infrastructure. The region is home to a plethora of world-renowned medical institutions, cutting-edge research centers, and innovative healthcare providers. This robust healthcare ecosystem naturally lends itself to the adoption of progressive medical practices, including the reprocessing of single-use devices. As a result, the market experiences a substantial influx of both demand and supply for reprocessed medical devices. Moreover, the stringent regulatory framework in North America serves as a catalyst for the adoption of safe and compliant reprocessing practices. Furthermore, the culture of innovation and technology adoption in North America contributes to the region's leadership in the market. Technological advancements in reprocessing techniques, sterilization methods, and quality control mechanisms are embraced more readily in this environment. Financial considerations also play a significant role in North America's dominance. The high costs associated with healthcare delivery, including the procurement of new medical devices, motivate healthcare institutions to explore cost-effective alternatives.
Companies are heavily investing in research and development to improve reprocessing techniques. This includes advancements in cleaning, disinfection, and sterilization methods to ensure that reprocessed devices meet or exceed regulatory requirements and maintain their safety and efficacy. Companies are also working closely with regulatory authorities to ensure that their reprocessed devices adhere to the necessary safety and quality standards. They engage in rigorous testing, validation, and documentation to demonstrate that reprocessed devices are equivalent to new ones in terms of performance and safety. Additionally, several companies are expanding their portfolios of reprocessed medical devices. Initially, the focus might have been on common devices, but as the market matures, companies are diversifying into more complex and specialized instruments used in various medical specialties. Moreover, companies are actively involved in educating healthcare professionals about the benefits and safety of reprocessed devices. This involves providing training sessions, workshops, webinars, and educational materials to ensure that healthcare providers have a clear understanding of the reprocessing process and the quality assurances in place.
Arjo Inc.
Innovative Health
Johnson & Johnson
Medline Industries LP
NEScientific Inc.
Steripro Canada
Stryker Corporation
SureTek Medical
Vanguard AG
In January 2022, Innovative Health was granted permission to reprocess Boston Scientific's INTELLAMAP ORION High-resolution Mapping Catheter. The catheter is commonly used in atrial fibrillation catheter ablation operations.
In December 2020, Arjo Inc. announced the acquisition of AirPal, a privately owned US-based company specializing in Air-Assisted Lateral Patient Transfer solutions. The acquisition is part of the Group's long-term strategic focus towards driving healthier outcomes for people facing mobility challenges.
In December 2020, Medline Industries LP launched two Healthcare Sustainability Programs. The programs, a Green Product Portfolio, and a Sustainable Packaging Lab, will help hospitals reduce the amount of product waste coming out of their facilities.